{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:49:16Z","timestamp":1794473356565,"version":"4.9.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ijcard.2025.133613","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:50:32Z","timestamp":1752580232000},"page":"133613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Safety and efficacy of P2Y12 inhibitors in acute coronary syndromes patients with KDIGO stage IV-V renal disfunction not on dialysis: a subanalysis of the CORALYS registry"],"prefix":"10.1016","volume":"439","author":[{"given":"Federico","family":"Giacobbe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giannino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Siliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Morena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Truffa Giachet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Sagazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"D'Ascenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Marchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ghisletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Pagliassotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guglielmo","family":"Gallone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Dusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Patti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Wanha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano Maria","family":"De Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidio","family":"De Filippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.ijcard.2025.133613_bb0005","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/j.jcin.2017.02.047","article-title":"Associations between chronic kidney disease and outcomes with use of prasugrel versus clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the PROMETHEUS study","volume":"10","author":"Baber","year":"2017","journal-title":"JACC Cardiovasc. Interv."},{"issue":"19","key":"10.1016\/j.ijcard.2025.133613_bb0010","first-page":"1575","article-title":"Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function","volume":"104","author":"Edfors","year":"2018","journal-title":"Heart Br. Card. Soc."},{"issue":"11","key":"10.1016\/j.ijcard.2025.133613_bb0015","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"9731","key":"10.1016\/j.ijcard.2025.133613_bb0020","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Chronic Kidney Disease Prognosis Consortium","year":"2010","journal-title":"Lancet Lond. Engl."},{"issue":"3","key":"10.1016\/j.ijcard.2025.133613_bb0025","first-page":"352","article-title":"Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention","volume":"80","author":"Parikh","year":"2012","journal-title":"Catheter. Cardiovasc. Interv. Off. J. Soc. Card. Angiogr. Interv."},{"key":"10.1016\/j.ijcard.2025.133613_bb0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2369-15-66","article-title":"Impact of impaired glomerular filtration rate and revascularization strategy on one-year cardiovascular events in acute coronary syndrome: data from Taiwan acute coronary syndrome full spectrum registry","volume":"15","author":"Lin","year":"2014","journal-title":"BMC Nephrol."},{"issue":"20","key":"10.1016\/j.ijcard.2025.133613_bb0035","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.ijcard.2025.133613_bb0040","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/eurheartj\/ehad870","volume":"45","year":"2024","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ijcard.2025.133613_bb0045","first-page":"101","article-title":"Biological efficacy of a 600 mg loading dose of clopidogrel in ST-elevation myocardial infarction","volume":"108","author":"Bonello","year":"2012","journal-title":"Thromb. Haemost."},{"issue":"24","key":"10.1016\/j.ijcard.2025.133613_bb0050","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.jacc.2013.07.101","article-title":"Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding","volume":"62","author":"Tantry","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9892","key":"10.1016\/j.ijcard.2025.133613_bb0055","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(13)61170-8","article-title":"Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study","volume":"382","author":"Stone","year":"2013","journal-title":"Lancet Lond. Engl."},{"issue":"12","key":"10.1016\/j.ijcard.2025.133613_bb0060","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1111\/j.1538-7836.2011.04531.x","article-title":"Antiplatelet effects of prasugrel vs. double clopidogrel in patients on hemodialysis and with high on-treatment platelet reactivity","volume":"9","author":"Alexopoulos","year":"2011","journal-title":"J. Thromb. Haemost."},{"issue":"25","key":"10.1016\/j.ijcard.2025.133613_bb0065","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/CIRCULATIONAHA.107.740324","volume":"116","author":"Wiviott","year":"2007","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.ijcard.2025.133613_bb0070","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","article-title":"Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study","volume":"120","author":"Gurbel","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcard.2025.133613_bb0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2796.2009.02204.x","article-title":"Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register","volume":"268","author":"Szummer","year":"2010","journal-title":"J. Intern. Med."},{"issue":"15","key":"10.1016\/j.ijcard.2025.133613_bb0080","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1161\/CIRCULATIONAHA.118.032078","article-title":"P2Y12-ADP receptor blockade in chronic kidney disease patients with acute coronary syndromes","volume":"138","author":"Bonello","year":"2018","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2025.133613_bb0085","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ahj.2009.01.003","article-title":"Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: rationale, design, and baseline characteristics of the PLATelet inhibition and patient outcomes (PLATO) trial","volume":"157","author":"James","year":"2009","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/j.ijcard.2025.133613_bb0090","doi-asserted-by":"crossref","first-page":"2154330","DOI":"10.1080\/09537104.2022.2154330","article-title":"Treatment inequity in antiplatelet therapy for ischaemic heart disease in patients with advanced chronic kidney disease: releasing the evidence vacuum","volume":"34","author":"Varian","year":"2023","journal-title":"Platelets"},{"issue":"6","key":"10.1016\/j.ijcard.2025.133613_bb0095","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/clc.22253","article-title":"Clinical features, use of evidence-based therapies, and cardiovascular outcomes among patients with chronic kidney disease following non-ST-elevation acute coronary syndrome","volume":"37","author":"Rhee","year":"2014","journal-title":"Clin. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2025.133613_bb0100","first-page":"113","article-title":"Increased activated protein C: protein C inhibitor complex and decreased protein C inhibitor levels in patients with chronic renal failure on maintenance hemodialysis","volume":"5","author":"Takagi","year":"1999","journal-title":"Clin. Appl. Thromb. Off. J. Int. Acad. Clin. Appl. Thromb."},{"issue":"4","key":"10.1016\/j.ijcard.2025.133613_bb0105","first-page":"163","article-title":"Extrinsic coagulation factors and tissue factor pathway inhibitor in end-stage chronic renal failure","volume":"27","author":"Matsuo","year":"1997","journal-title":"Haemostasis"},{"issue":"7","key":"10.1016\/j.ijcard.2025.133613_bb0110","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/MBC.0b013e32832da16d","article-title":"Tissue factor\/its pathway inhibitor system and kynurenines in chronic kidney disease patients on conservative treatment","volume":"20","author":"Pawlak","year":"2009","journal-title":"Blood Coagul. Fibrinolysis Int. J. Haemost. Thromb."},{"issue":"9","key":"10.1016\/j.ijcard.2025.133613_bb0115","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2174\/138945007781662373","article-title":"PAI-1 as a target in kidney disease","volume":"8","author":"Huang","year":"2007","journal-title":"Curr. Drug Targets"},{"issue":"1","key":"10.1016\/j.ijcard.2025.133613_bb0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0049-3848(91)90207-D","article-title":"Coagulation and fibrinolysis in patients with chronic renal failure undergoing conservative treatment","volume":"64","author":"Tomura","year":"1991","journal-title":"Thromb. Res."},{"issue":"12","key":"10.1016\/j.ijcard.2025.133613_bb0125","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/ajh.20720","article-title":"Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa","volume":"81","author":"Thekkedath","year":"2006","journal-title":"Am. J. Hematol."},{"issue":"2\u20133","key":"10.1016\/j.ijcard.2025.133613_bb0130","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000014385","article-title":"Uremic ultrafiltrate inhibits platelet-activating factor synthesis","volume":"17","author":"Wratten","year":"1999","journal-title":"Blood Purif."},{"issue":"1","key":"10.1016\/j.ijcard.2025.133613_bb0135","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/bcp.13436","article-title":"Pharmacodynamics and pharmacokinetics of ticagrelor vs. clopidogrel in patients with acute coronary syndromes and chronic kidney disease","volume":"84","author":"Wang","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.ijcard.2025.133613_bb0140","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1055\/s-2004-835678","article-title":"Platelet dysfunction in renal failure","volume":"30","author":"Boccardo","year":"2004","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.ijcard.2025.133613_bb0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ahj.2020.04.013","article-title":"TicagRelor or clopidogrel in severe or terminal chronic kidney patients undergoing PERcutaneous coronary intervention for acute coronary syndrome: the TROUPER trial","volume":"225","author":"Laine","year":"2020","journal-title":"Am. Heart J."},{"issue":"6","key":"10.1016\/j.ijcard.2025.133613_bb0150","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1053\/j.ajkd.2011.12.027","article-title":"Association of estimated GFR with platelet inhibition in patients treated with clopidogrel","volume":"59","author":"Muller","year":"2012","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"issue":"13","key":"10.1016\/j.ijcard.2025.133613_bb0155","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1161\/CIRCULATIONAHA.118.034790","article-title":"Study of two dose regimens of ticagrelor compared with clopidogrel in patients undergoing percutaneous coronary intervention for stable coronary artery disease","volume":"138","author":"Orme","year":"2018","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ijcard.2025.133613_bb0160","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jacc.2009.10.043","article-title":"Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy","volume":"55","author":"Angiolillo","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2025.133613_bb0165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14017431.2019.1598571","article-title":"High on-clopidogrel platelet reactivity and chronic kidney disease: a meta-analysis of literature studies","volume":"53","author":"Wu","year":"2019","journal-title":"Scand. Cardiovasc. J."},{"issue":"1","key":"10.1016\/j.ijcard.2025.133613_bb0170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/ehjcvp\/pvz048","article-title":"P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects","volume":"6","author":"De Filippo","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"issue":"2","key":"10.1016\/j.ijcard.2025.133613_bb0175","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/09537100701694144","article-title":"The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory platelet responses","volume":"19","author":"Judge","year":"2008","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.ijcard.2025.133613_bb0180","first-page":"96","article-title":"Morphine delays the onset of action of prasugrel in patients with prior history of ST-elevation myocardial infarction","volume":"116","author":"Thomas","year":"2016","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.ijcard.2025.133613_bb0185","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jjcc.2018.07.001","article-title":"High residual platelet reactivity after switching from clopidogrel to low-dose prasugrel in Japanese patients with end-stage renal disease on hemodialysis","volume":"73","author":"Ohno","year":"2019","journal-title":"J. Cardiol."},{"issue":"14","key":"10.1016\/j.ijcard.2025.133613_bb0190","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJMoa1205512","article-title":"Prasugrel versus clopidogrel for acute coronary syndromes without revascularization","volume":"367","author":"Roe","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ijcard.2025.133613_bb0195","first-page":"843","article-title":"Safety and efficacy of drug-eluting stents for patients at high risk of bleedings: a network meta-analysis","volume":"103","author":"Giacobbe","year":"2024","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"3","key":"10.1016\/j.ijcard.2025.133613_bb0200","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ijcard.2025.133613_bb0205","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12916-018-1145-0","article-title":"Practical issues in clinical scenarios involving CKD patients requiring antithrombotic therapy in light of the 2017 ESC guideline recommendations","volume":"16","author":"Covic","year":"2018","journal-title":"BMC Med."},{"issue":"10270","key":"10.1016\/j.ijcard.2025.133613_bb0210","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0140-6736(20)32519-8","article-title":"Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets","volume":"397","author":"D\u2019Ascenzo","year":"2021","journal-title":"Lancet Lond. Engl."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527325006564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527325006564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T04:50:53Z","timestamp":1757911853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527325006564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":42,"alternative-id":["S0167527325006564"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.133613","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of P2Y12 inhibitors in acute coronary syndromes patients with KDIGO stage IV-V renal disfunction not on dialysis: a subanalysis of the CORALYS registry","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.133613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"133613"}}